e-learning
resources
Vienna 2009
Sunday, 13.09.2009
COPD: basic science and clinical studies
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Non-neuronal components of cholinergic system in peripheral blood T-cells of COPD patients
M. Profita, L. Riccobono, A. M. Montalbano, M. Ferraro, S. Gerbino, A. Bruno, G. D. Albano, M. P. Pieper, M. Gjomarkaj (Palermo, Italy; Biberach, Germany)
Source:
Annual Congress 2009 - COPD: basic science and clinical studies
Session:
COPD: basic science and clinical studies
Session type:
Thematic Poster Session
Number:
915
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Profita, L. Riccobono, A. M. Montalbano, M. Ferraro, S. Gerbino, A. Bruno, G. D. Albano, M. P. Pieper, M. Gjomarkaj (Palermo, Italy; Biberach, Germany). Non-neuronal components of cholinergic system in peripheral blood T-cells of COPD patients. Eur Respir J 2009; 34: Suppl. 53, 915
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion on ERS Statement – A core outcome set for clinical trials evaluating the management of COPD exacerbations
ERS statement: a core outcome set for clinical trials evaluating the management of COPD exacerbations
Evidence-based eHealth for COPD
Related content which might interest you:
Changes in muscarinic cholinergic receptor expression in human peripheral blood lymphocytes in allergic rhinitis patients
Source: Eur Respir J 2006; 28: Suppl. 50, 748s
Year: 2006
Characterisation of dendritic cells generated from peripheral blood monocytes of NSCLC patients
Source: Annual Congress 2007 - Biology of thoracic malignancies
Year: 2007
Are complexemia and expression of FcγR and CR receptors on peripheral blood monocytes involved in the etiopathogenesis of sarcoidosis?
Source: Annual Congress 2010 - Macrophages: cell biology and disease-specific characteristics
Year: 2010
Cytokine releasing mucosa-homing T cells are increased in peripheral blood of pulmonary fibrosis patients
Source: Annual Congress 2010 - Pathogenesis of diffuse parenchymal lung disease
Year: 2010
Activation of immune cell proteasomes in peripheral blood of smokers and COPD patients: implications for therapy
Source: Eur Respir J, 59 (3) 2101798; 10.1183/13993003.01798-2021
Year: 2022
Posaconazole in vitro action on peripheral blood mononuclear cells from sarcoidosis patients
Source: International Congress 2017 – The many faces of sarcoidosis
Year: 2017
In vitro responses of peripheral blood mononuclear cells in severe asthma patient treated with Mepolizumab
Source: Virtual Congress 2020 – Novel immunopathological mechanisms of lung disease: knowledge from translational studies
Year: 2020
The complex role of SOCS1 expression in peripheral blood mononuclears of patients with bronchial asthma
Source: Annual Congress 2012 - Cell biology and inflammatory gene expression in chronic lung disease
Year: 2012
Cytokine production by peripheral blood monocytes and subsets of dendritic cells from MDR-TB patients
Source: Annual Congress 2003 - Genetics and immunobiology of tuberculosis
Year: 2003
Treatment of COPD exacerbations is able to influence the mononuclear cells level of the peripheral blood
Source: Annual Congress 2008 - Basic science in asthma and COPD II
Year: 2008
Glucocorticoid sensitivity of peripheral mononuclear cells in children with asthma
Source: Annual Congress 2008 - Assessment of inflammation, hyperresponsiveness and response to exercise in asthmatic children
Year: 2008
Decreased numbers of human peripheral blood CD8+ve T-lymphocytes and the modification of their specific surface antigens in COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 309s
Year: 2002
T cells in peripheral blood during viral acute exacerbation of COPD
Source: Annual Congress 2012 - Hot topics in respiratory infections
Year: 2012
The fraction of circulating type 2 innate lymphoid cells in peripheral blood is associated with asthma severity
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of asthma
Year: 2019
Central/effector memory T-cell dynamics in the peripheral blood of patients with active pulmonary tuberculosis
Source: Eur Respir J 2002; 20: Suppl. 38, 10s
Year: 2002
Biology of peripheral blood inflammatory cells in OSAS
Source: Research Seminar 2007 - Metabolic Aspects of the Obstructive Sleep Apnea Syndrome (OSAS)
Year: 2007
Characterization of peripheral subsets of dendritic cells in COPD patients: preliminary data
Source: Annual Congress 2008 - Invasive and noninvasive measurements of lung inflammation
Year: 2008
Peripheral blood Th17 and Th17/Th2 cells and their association with lung function and biomarkers in asthma-COPD overlap syndrome
Source: International Congress 2017 – Systemic and airway biomarkers
Year: 2017
Levels of CD4CD25 T regulatory cells in bronchial mucosa and peripheral blood of chronic obstructive pulmonary disease indicate involvement of autoimmunity mechanisms
Source: International Congress 2019 – Immunopathological mechanisms of lung disease
Year: 2019
Peripheral blood memory T-helper (Th) 17 subsets in patients with chronic and acute pulmonary sarcoidosis
Source: International Congress 2018 – Granulomatous disorders: epidemiology, genotype and phenotype
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept